JP7123034B2 - 保存効力又は光安定性が改善された点眼用医薬組成物 - Google Patents

保存効力又は光安定性が改善された点眼用医薬組成物 Download PDF

Info

Publication number
JP7123034B2
JP7123034B2 JP2019507970A JP2019507970A JP7123034B2 JP 7123034 B2 JP7123034 B2 JP 7123034B2 JP 2019507970 A JP2019507970 A JP 2019507970A JP 2019507970 A JP2019507970 A JP 2019507970A JP 7123034 B2 JP7123034 B2 JP 7123034B2
Authority
JP
Japan
Prior art keywords
pharmaceutically acceptable
acceptable salt
pharmaceutical composition
carteolol
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2019507970A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019526549A5 (enExample
JP2019526549A (ja
Inventor
良治 長濱
文雄 近藤
優 大八木
雄樹 平田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of JP2019526549A publication Critical patent/JP2019526549A/ja
Publication of JP2019526549A5 publication Critical patent/JP2019526549A5/ja
Priority to JP2022127009A priority Critical patent/JP2022172124A/ja
Application granted granted Critical
Publication of JP7123034B2 publication Critical patent/JP7123034B2/ja
Priority to JP2024077741A priority patent/JP2024112862A/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4704—2-Quinolinones, e.g. carbostyril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2019507970A 2016-08-23 2017-08-22 保存効力又は光安定性が改善された点眼用医薬組成物 Active JP7123034B2 (ja)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2022127009A JP2022172124A (ja) 2016-08-23 2022-08-09 保存効力又は光安定性が改善された点眼用医薬組成物
JP2024077741A JP2024112862A (ja) 2016-08-23 2024-05-13 保存効力又は光安定性が改善された点眼用医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2016162611 2016-08-23
JP2016162611 2016-08-23
PCT/JP2017/029934 WO2018038102A1 (en) 2016-08-23 2017-08-22 Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022127009A Division JP2022172124A (ja) 2016-08-23 2022-08-09 保存効力又は光安定性が改善された点眼用医薬組成物

Publications (3)

Publication Number Publication Date
JP2019526549A JP2019526549A (ja) 2019-09-19
JP2019526549A5 JP2019526549A5 (enExample) 2020-08-13
JP7123034B2 true JP7123034B2 (ja) 2022-08-22

Family

ID=59812062

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2019507970A Active JP7123034B2 (ja) 2016-08-23 2017-08-22 保存効力又は光安定性が改善された点眼用医薬組成物
JP2022127009A Pending JP2022172124A (ja) 2016-08-23 2022-08-09 保存効力又は光安定性が改善された点眼用医薬組成物
JP2024077741A Pending JP2024112862A (ja) 2016-08-23 2024-05-13 保存効力又は光安定性が改善された点眼用医薬組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022127009A Pending JP2022172124A (ja) 2016-08-23 2022-08-09 保存効力又は光安定性が改善された点眼用医薬組成物
JP2024077741A Pending JP2024112862A (ja) 2016-08-23 2024-05-13 保存効力又は光安定性が改善された点眼用医薬組成物

Country Status (4)

Country Link
JP (3) JP7123034B2 (enExample)
CN (3) CN115444849B (enExample)
TW (4) TW202332446A (enExample)
WO (1) WO2018038102A1 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022131565A (ja) * 2021-02-26 2022-09-07 ロート製薬株式会社 水性医薬組成物
CN114788809B (zh) * 2022-01-25 2023-04-14 江苏广承药业有限公司 一种氯雷他定液体制剂

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004315365A (ja) 2003-02-25 2004-11-11 Rohto Pharmaceut Co Ltd ケトチフェン含有組成物
JP2016065088A (ja) 2003-09-30 2016-04-28 ロート製薬株式会社 透明包装体入りトラニラスト含有医薬製剤

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH01135887A (ja) * 1987-11-20 1989-05-29 Lion Corp 紫外線吸収剤組成物
FR2777189B1 (fr) * 1998-04-09 2001-04-06 Chauvin Lab Sa Composition ophtalmique comprenant un beta-bloquant
KR20060102282A (ko) * 2005-03-22 2006-09-27 테이카 세이야쿠 가부시키가이샤 점안제
US20070077302A1 (en) * 2005-09-30 2007-04-05 Azaam Alli Methods for stabilizing ophthalmic compositions
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur
JP5661456B2 (ja) * 2008-04-23 2015-01-28 大塚製薬株式会社 点眼剤及び使用方法
CN101461780A (zh) 2009-01-06 2009-06-24 河北科技大学 不含抑菌剂的盐酸卡替洛尔滴眼液及其制备方法
TW201109325A (en) 2009-07-30 2011-03-16 Wakamoto Pharma Co Ltd Aqueous composition for eye drops
CN103079595B (zh) * 2010-08-27 2015-11-25 若素制药株式会社 滴眼用水性组合物
CN104136019A (zh) * 2012-02-27 2014-11-05 日本乐敦制药株式会社 眼科用组合物试剂盒

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004315365A (ja) 2003-02-25 2004-11-11 Rohto Pharmaceut Co Ltd ケトチフェン含有組成物
JP2016065088A (ja) 2003-09-30 2016-04-28 ロート製薬株式会社 透明包装体入りトラニラスト含有医薬製剤

Also Published As

Publication number Publication date
TW202513068A (zh) 2025-04-01
TWI814709B (zh) 2023-09-11
TW201811331A (zh) 2018-04-01
CN115444849A (zh) 2022-12-09
CN115444849B (zh) 2025-07-01
CN115463130A (zh) 2022-12-13
JP2022172124A (ja) 2022-11-15
JP2024112862A (ja) 2024-08-21
JP2019526549A (ja) 2019-09-19
TW202332446A (zh) 2023-08-16
TW202231276A (zh) 2022-08-16
CN109641059A (zh) 2019-04-16
CN109641059B (zh) 2022-08-30
TWI828025B (zh) 2024-01-01
WO2018038102A1 (en) 2018-03-01

Similar Documents

Publication Publication Date Title
TWI849355B (zh) 含阿托平之水性組成物及其用途
JP5901087B2 (ja) 点眼用水性組成物
CN102958509A (zh) 用于不含防腐剂的非粘性前列腺素类溶液的聚合物给药系统
JP2024112862A (ja) 保存効力又は光安定性が改善された点眼用医薬組成物
RU2745317C2 (ru) Фармацевтическая композиция, включающая дорзоламид и бримонидин
US9561280B2 (en) Aqueous liquid bromfenac composition having preservative efficacy
HK40082706A (zh) 具有改善的防腐效力或光稳定性的眼科药物组合物
HK40082707A (en) Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability
RU2745617C2 (ru) Антисептическое средство, включающее меглюмин или его соль
UA115454C2 (uk) Композиція фінафлоксацину у вигляді суспензії
JP6877613B2 (ja) 防腐効果のある医薬の組合せ
TW202404569A (zh) 含有賽佩普斯特(Sepetaprost)之眼科用組合物
JP2016216442A (ja) ドルゾラミドを含有する防腐剤
WO2024135837A1 (ja) 組織移行性及び防腐効力を向上させるエピナスチン含有水性組成物
JP2022123792A (ja) 水性医薬組成物
RU2776062C2 (ru) Жидкая композиция с бромфенаком на водной основе, обладающая консервирующей эффективностью

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200702

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200702

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210803

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210921

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20211109

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220105

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20220712

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20220809

R150 Certificate of patent or registration of utility model

Ref document number: 7123034

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250